Skip to main content
. 2000 Jul 24;2000(3):CD000212. doi: 10.1002/14651858.CD000212

2. Psoriatic arthritis versus Rheumatoid arthritis.

   
placebo vs baseline 0.39 (+0.26‐+0.52) 0.15 (+0.11‐+0.19)
   
treatment vs placebo  
Auranofin 0.12(‐0.13‐+0.38) 0.30 (+0.06‐+0.54)
IM Gold 0.23 (‐0.13‐+0.38) 0.56 (+0.11‐+1.01
Methotrexate 0.65 (‐0.00‐+1.30) 0.58 (+0.10‐+1.06)
Salazopyrin 0.38 (+0.21‐+0.54) 0.60 (+0.18‐+1.02)